Recovery Management Intervention in China
|ClinicalTrials.gov Identifier: NCT01270100|
Recruitment Status : Completed
First Posted : January 5, 2011
Last Update Posted : January 5, 2011
The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China.
The project has the following specific aims:
Aim 1. To engage key stakeholders in the local communities involved in supporting the transition of heroin addicts released from compulsory rehabilitation to the community; Aim 2. To identify potential barriers for participating in MMT in China; Aim 3. To develop and deliver educational/training materials on HIV risks, relapse prevention, and MMT; Aim 4. To adapt and develop the Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China; Aim 5. To conduct a pilot trial and obtain preliminary outcome data associated with RMI, relative to enhanced standard care.
Aim 6. To explore predictors of relapse and HIV/AIDS risk behaviors.
It is hypothesized that the intervention will reduce drug use relapse and the negative consequences associated with relapse, including HIV risk behaviors
|Condition or disease||Intervention/treatment|
|Methadone HIV Infections||Behavioral: Recovery management|
|Study Type :||Interventional (Clinical Trial)|
|Official Title:||Reducing HIV/AIDS and Drug Abuse Among Heroin Addicts Released From Compulsory Rehabilitation in China|
|Experimental: Recovery management intervention||Behavioral: Recovery management|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01270100
|Shanghai Mental Health Center|